Medifast
MED
113 hedge funds and large institutions have $87.7M invested in Medifast in 2026 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 43 increasing their positions, 28 reducing their positions, and 24 closing their positions.
679% more call options, than puts
Call options by funds: $15.9M | Put options by funds: $2.04M
54% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 28
8% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 24
1% more funds holding
Funds holding: 112 → 113 (+1)
0% more capital invested
Capital invested by funds: $87.6M → $87.7M (+$28.4K)
3.96% less ownership
Funds ownership: 78.27% → 74.3% (-4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$2.79M |
| 2 |
Two Sigma Investments
New York
|
+$1.65M |
| 3 |
CC
Commons Capital
Needham,
Massachusetts
|
+$1.29M |
| 4 |
RC
RBF Capital
San Francisco,
California
|
+$1.26M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$1.09M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$6.63M |
| 2 |
Charles Schwab
San Francisco,
California
|
-$2.71M |
| 3 |
Man Group
London,
United Kingdom
|
-$2.41M |
| 4 |
Vanguard Portfolio Management
Malvern,
Pennsylvania
|
-$2M |
| 5 |
State Street
Boston,
Massachusetts
|
-$1.96M |
MED Hedge Fund Activity: Q2 2026 in Review
113 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q2 2026, worth a combined $87.7M — up 0.03% from $87.6M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new MED positions and 24 closed out — a net gain of 2 holders — while 43 added to existing stakes and 28 trimmed.
The largest buyer was Marshall Wace, opening a new position worth an estimated $2.79M. The largest seller was BlackRock, cutting an estimated $6.63M.
- 113 institutional investors held Medifast (MED) as of Q2 2026, up from 112 in Q1 2026.
- Funds reported $87.7M of Medifast stock for Q2 2026, up 0.03% quarter-over-quarter.
- 26 funds opened new Medifast positions in Q2 2026 and 24 closed out, a net change of +2 holders.
- The largest Medifast buyer in Q2 2026 was Marshall Wace, an estimated $2.79M added.
- The largest Medifast seller in Q2 2026 was BlackRock, an estimated $6.63M sold.
Based on aggregated 13F filings for Q2 2026.